Schaeffer's Top Stock Picks for '25

EpiPen Maker Stung by Earnings Miss, Bear Notes

Mylan's weak earnings and guidance has prompted at least five bear notes

Managing Editor
Feb 27, 2019 at 9:30 AM
facebook X logo linkedin


The shares of Mylan NV (NASDAQ:MYL) are down 10% in electronic trading, after the EpiPen producer reported adjusted fourth-quarter profit of $1.30, falling short of analysts' $1.36 per share estimate. The drugmaker's 2019 profit forecast also was beneath expectations, prompting five price-target cuts, including one to $36 from $41 at Raymond James.  

Should today's pre-market price action pan out, this would be Mylan stock's worst single-session drop since Feb. 11, 2016, when it dropped 18.1%. Prior to today, MYL had added 11.8% year-to-date, but had rallied back up to its 120-day moving average, a trendline with historically bearish implications.

Today's shift in analyst sentiment could be just the beginning. Of the 14 brokerages covering MYL, nine rate it a "buy" or better, with zero "sells" on the books. Plus, its consensus 12-month price target of $37.64 is a 23% premium to last night's close at $30.62.

There's also ample room for short sellers to climb on board. Short interest actually fell by 24% in the last two reporting periods to 6.12 million shares, a meager 1.2% of the security's total available float. MYL's inability to take advantage of this exodus of bearish bets only underscores its technical weakness.

In the options pits, data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows the security with a 10-day put/call volume ratio of 0.73, which ranks in the 79th percentile of its annual range. While this indicates that bought calls have outnumbered puts on an absolute basis, the elevated percentile ranking tells us option buyers have purchased MYL puts over calls at a faster-than-usual pace in the past two weeks.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));